Literature DB >> 12090814

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.

Alexander Neumeister1, Anastasios Konstantinidis, Juergen Stastny, Markus J Schwarz, Oliver Vitouch, Matthaus Willeit, Nicole Praschak-Rieder, Johanna Zach, Martina de Zwaan, Brigitta Bondy, Manfred Ackenheil, Siegfried Kasper.   

Abstract

BACKGROUND: Evidence suggests that serotonin transporter gene promoter polymorphism (5HTTLPR)-dependent low transcriptional activity of the human serotonin transporter gene may be a genetic susceptibility factor for depression. We studied the behavioral responses to tryptophan depletion (TD) in healthy women with and without a first-degree family history of depression and examined the relationship to 5HTTLPR alleles.
METHODS: Twenty-four healthy women with a negative family history of depression and 21 women with a positive family history of depression were genotyped for the polymorphism of the 5HTTLPR and then entered a double-blind, placebo-controlled, randomized crossover TD study. The effects of these interventions were assessed with measures of depression and plasma tryptophan levels.
RESULTS: The TD induced a robust decrease of plasma tryptophan levels in all women irrespective of family history of depression or 5HTTLPR genotypes. The s/s genotype of the 5HTTLPR was associated with an increased risk of developing depressive symptoms during TD irrespective of family history. In contrast, individuals with the l/l genotype did not develop depressive symptoms, irrespective of family history. Finally, s/l subjects without family history showed a mood response that was intermediate between the s/s and l/l subjects, while s/l subjects with a family history of depression showed the same depressiogenic effect of TD as seen in the s/s subjects.
CONCLUSIONS: The results of the present study suggest that the s-allele of the 5HTTLPR and a positive family history of depression are additive risk factors for the development of depression during TD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090814     DOI: 10.1001/archpsyc.59.7.613

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  57 in total

1.  The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.

Authors:  Jonathan P Roiser; Robert D Rogers; Lynnette J Cook; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2006-08-29       Impact factor: 4.530

Review 2.  [The effects of hormone replacement therapy on mind and brain].

Authors:  P Baldinger; G Kranz; A Höflich; M Savli; P Stein; R Lanzenberger; S Kasper
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

3.  Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

4.  The role of 5-HTTLPR in choosing the lesser of two evils, the better of two goods: examining the impact of 5-HTTLPR genotype and tryptophan depletion in object choice.

Authors:  K S Blair; E Finger; A A Marsh; J Morton; K Mondillo; B Buzas; D Goldman; W C Drevets; R J R Blair
Journal:  Psychopharmacology (Berl)       Date:  2007-10-17       Impact factor: 4.530

Review 5.  Neurobiological mechanisms in major depressive disorder.

Authors:  Marije aan het Rot; Sanjay J Mathew; Dennis S Charney
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

6.  Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

Authors:  Gianluigi Guidotti; Francesca Calabrese; Francesca Auletta; Jocelien Olivier; Giorgio Racagni; Judith Homberg; Marco A Riva
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

7.  Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.

Authors:  Jonathan P Roiser; Lynnette J Cook; Jason D Cooper; David C Rubinsztein; Barbara J Sahakian
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

Review 8.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

Review 9.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 10.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.